AbbVie's MAVYRET™ (glecaprevir/pibrentasvir) Shows High Virologic Cure* Rates in Treatment-Naïve Hepatitis C Patients with Compensated Cirrhosis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/20/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. AAPL
6. RTB
7. ONON
8. AZN
9. SPCX
10. TRMD

Go back to AbbVie's MAVYRET™ (glecaprevir/pibrentasvir) Shows High Virologic Cure* Rates in Treatment-Naïve Hepatitis C Patients with Compensated Cirrhosis
AbbVie (NYSE: ABBV) Delayed: 263.96 -0.06 (0.02%)
Previous Close $264.02    52 Week High $68.12 
Open $263.29    52 Week Low $50.71 
Day High $266.34    P/E 57.26 
Day Low $262.44    EPS $4.61 
Volume 8,176,594       

ENANTA PHARM (NASDAQ: ENTA) Delayed: 12.20 -0.32 (2.56%)
Previous Close $12.52    52 Week High $34.49 
Open $12.49    52 Week Low $20.39 
Day High $12.61    P/E N/A 
Day Low $12.19    EPS $-3.18 
Volume 428,248